top of page
scale-2022-black.png.webp

Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience. 

SYNCHRONOUS ULTRASOUND PARALLEL BEAM TECHNOLOGY FOR ACNE SCARS APPERANCE IMPROVEMENT

Primary Author: Ruthie Amir Phd

Industry1.png
Industry_1_.png

Improving Temple Hollowing With a Hyaluronic Acid Injectable Gel, VYC-20L: Results From a Multicenter, Randomized, Evaluator-Blinded, Controlled Pivotal Study

Primary Author: Brian Biesman MD

Industry2.png
Industry_2_.png

Creation and Validation of a Photonumeric Scale for Assessment of Midface Volume Deficit

Primary Author: Agnès Bury MSc

Industry3.png
Industry_3.png

Effectiveness of Acoustic Subcision Treatment Delivered via Rapid Acoustic Pulse Technology for the Improvement of Skin Laxity Appearance: Results From a Retrospective, Independent, Blinded Photo Assessment

Primary Author: Christopher Capelli MD

Industry4.png
Industry_4.png

A Multi-Action Facial Night Cream Containing Macrocystis pyrifera Ferment and extracts from Crithmum maritimum and Laminaria digitata Delivers Ageless Benefits Over Night and Over Time

Primary Author: Lisa DiNatale MS

Industry5.png
Industry_5.png

Evaluation of a new moisturizer developed to address three critical elements of natural moisturization in participants with moderate-to-severe dry, dehydrated facial skin

Primary Author: Zoe Draelos MD

Industry6.png
Industry_6_.png

Changes in TNF-α Levels in Psoriatic Plaques After Treatment With Fixed-Combination Halobetasol Propionate and Tazarotene Lotion Versus Clobetasol Propionate 0.05% Cream

Primary Author: Zoe Draelos MD

Industry7.png
Industry_7_.png

Improvement in skin moisturization and lack of skin barrier damage following treatment with clascoterone cream 1%: A randomized, single-blind, split-face study in acne-prone individuals

Primary Author: Zoe Draelos MD

Industry8.png
Industry_8.png

Phase 2b, Randomized, Double-blind, Placebo-controlled, Multicenter, Global Study to Evaluate the Efficacy and Safety of ANB032 in the Treatment of Subjects with Moderate to Severe Atopic Dermatitis

Primary Author: Benjamin Ehst M.D., Ph.D.

Industry9.png
Industry_9_.png

A Complex of Three Marine Extracts Exhibits “Retinol-like” Anti-aging Mechanisms without Stimulating an Acute Inflammatory Response

Primary Author: Jaime Emmetsberger PhD

Industry10.png
Industry_10.png

EVALUATION OF THE PROTECTION OF SUNSCREEN PRODUCTS AGAINST LONG WAVELENGTH ULTRAVIOLET A1 AND VISIBLE LIGHT-INDUCED BIOLOGICAL EFFECTS

Primary Author: Nneamaka Ezekwe MD

Industry11.png
Industry_11.png

Micro-focused ultrasound with visualization aesthetic outcomes: a systematic review and meta-analysis of clinical studies

Primary Author: Sabrina Fabi MD

Industry12.png
Industry_12.png

Aesthetic concerns regarding body skin quality: Results from a large survey of aesthetically-inclined adults in the United States

Primary Author: Sabrina Fabi MD

Industry13.png
Industry_13.png

Treatment With Novel Dual-Applicator Cryolipolysis System Yields Significant Reduction in Fat Layer Thickness: Results From a Multicenter, Prospective Study

Primary Author: Sylvia Gamio MSc

Industry14.png
Industry_14.png

Importance of Posttreatment Follow-up With Patients in Aesthetic Practice

Primary Author: Julia Garcia PhD, MS

Industry15.png
Industry_15.png

CBL-514 Phase 2 Results Achieving Better Efficacy than Existing Invasive and Non-invasive Procedures for Fat Reduction

Primary Author: Michael Gold MD 

Industry16.png
Industry_16.png

Real-World Experience Using a Multi-Modality System that Combines IPL, 808, HIFU, RFM, and RF for Skin Rejuvenation Treatment

Michael Gold MD FAAD

Industry17.png
Industry_17.png

A systematic literature review and meta-analysis of the real-world effectiveness, quality of life, and safety of tildrakizumab for moderate-to-severe plaque psoriasis

Primary Author: Scott Gottlieb MD

Industry18.png
Industry_18.png

Early Acne Improvements With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: What to Expect in the First 4 Weeks of Treatment

Primary Author: Julie Harper MD

Industry19.png
Industry_19.png

Pooled safety assessments from the multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 trials of deuruxolitinib in adult patients with moderate-to-severe alopecia areata

Primary Author: Brett King MD, PhD

Industry20.png
Industry_20.png

Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: Comparison of 4 Clinical Trials

Primary Author: Leon Kircik MD

Industry21.png
Industry_21.png

Nemolizumab long-term efficacy and safety up to 52 weeks in the OLYMPIA open-label extension study in patients with prurigo nodularis: An interim analysis

Primary Author: Shawn G Kwatra MD

Industry22.png
Industry_22.png

Clinical Evaluation of Next-Generation, Multi-Weight Hyaluronic Acid Plus Antioxidant Complex-Based Topical Formulations with Targeted Delivery to Enhance Skin Rejuvenation

Primary Author: Edward (Ted) Lain MD, MBA

Industry23.png
Industry_23.png

The use of Aquaphilus dolomiae ferment filtrate recovery cream with topical corticosteroids, a potential option to mitigate concerns for dermal thinning and barrier disruption

Primary Author: Karan Lal D.O.

Industry24.png
Industry_24.png

The efficacy and safety of clascoterone cream 1% for the treatment of acne vulgaris are not dependent on patient age and sex: Results of a post hoc analysis

Primary Author: James Libecco MD

Industry25.png
Industry_25.png

Real-World Clinical Experience with a Neuro-Peptide Serum in Combination with Neurotoxin Injectables

Primary Author: Mark Lupin MD FRCPC

Industry26.png
Industry_26.png

Significantly Enhanced Improvement in Dryness, Roughness, Fine Lines and Radiance Following Daily Use of a Novel Multi-Weight Hyaluronic Acid Plus Antioxidant Complex-Based Lotion Compared to a Single-Weight HA Plus Ceramide-Based Lotion

Primary Author: Kavita Mariwalla MD

Screenshot 2024-05-14 at 10.55.17 AM.png
Updated_Industry.png

A Multi-Center, Double-Blind, Randomized, Comparator Controlled Trial Evaluating Topical Formulations for Skin Fragility of the Arms

Primary Author: Orit Markowitz MD

Industry28.png
Industry_28.png

Pooled patient-reported outcomes from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials of deuruxolitinib in adult patients with moderate-to-severe alopecia areata

Primary Author: Natasha Mesinkovska MD

Industry29.png
Industry_29.png

Efficacy of deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in scalp psoriasis by baseline Psoriasis Area and Severity Index (PASI) and baseline body surface area (BSA): a subanalysis of the phase 3 clinical trial data

Primary Author: Sahista Patel

Industry30.png
Industry_30.png

VISIBLE COHORT B: GUSELKUMAB IMPROVES KEY HEALTH-RELATED QUALITY OF LIFE MEASURES AT WEEK 16 IN PARTICIPANTS WITH MODERATE-TO-SEVERE SCALP PSORIASIS ACROSS ALL SKIN TONES

Primary Author: Jeff Pawlikowski

Industry31.png
Industry_31.png

A PHASE 2B, LONG-TERM EXTENSION, DOSE-RANGING STUDY OF ORAL JNJ-77242113 FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS: FRONTIER 2

Primary Author: Jeff Pawlikowski PhD

Industry32.png
Industry_32.png

Aesthetic concerns regarding facial skin quality: Results from a large survey of aesthetically-inclined adults in the United States

Primary Author: Mona Sadeghpour MD

Industry33.png
Industry_33.png

Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in plaque psoriasis: 3-year Psoriasis Area and Severity Index (PASI) outcomes in the long-term extension of the phase 3 POETYK PSO-1 and PSO-2 trials

Primary Author: Patel Sahista

Industry34.png
Industry_34.png

Efficacy of the oral JAK1/JAK2 inhibitor deuruxolitinib in adult patients with moderate-to-severe alopecia areata: Pooled results from the multinational, double-blind, placebo-controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 trials

Primary Author: Maryanne Senna MD

Industry35.png
Industry_35.png

Maintenance of Efficacy and Safety with Nemolizumab at Week 48: Results from Two Global Phase 3 Pivotal Studies (ARCADIA-1 and ARCADIA-2) in Patients with Moderate-to-Severe Atopic Dermatitis

Primary Author: Jonathan Silverberg MD

Industry36.png
Industry_36.png

Snail Extract for Skin: A Review of Uses, Projections, and Limitations

Primary Author: Nupur Singh BA

Industry37.png
Industry_37.png

Quality of Life in Participants With Hyperkeratotic Psoriasis Treated With Combination Halobetasol Propionate/Tazarotene Lotion

Primary Author: Linda Stein Gold MD

Industry38.png
Industry_38.png

Clinical Development Program of Novel Topical Nitric Oxide Releasing Medication Berdazimer Gel 10.3% for the Once-Daily Treatment of Molluscum Contagiosum

Primary Author: Stephen Stripling MD

Industry39.png
Industry_39.png

Evaluation of a skincare regimen comprised of a serum containing plant adaptogens and a cream addressing three components of moisturization pre- and post-laser treatment or a medium-depth chemical peel

Primary Author: Jacqueline Watchmaker MD, FAAD

Industry40.png
Industry_40.png

The Burden and Psychosocial Impact of Platysma Prominence

Primary Author: Steven Yoelin MD

Industry41.png
Industry_40 (1).png

Novel Post-Procedure Topical Treatment Enhances Patient Comfort Post-Hybrid Fractional Laser

Primary Author: Morgann Young MS

Screenshot 2024-05-14 at 10.34.37 AM.png
Industry_42.png

Post-Procedure Cream with Unique Neurotopical Technology Improves Patient Experience and Recovery following Fractional Ablative CO2 Laser Treatment

Primary Author: Alisar Zahr Ph

Screenshot 2024-05-14 at 10.39.24 AM.png
Industry_43.png

Evaluation of Antioxidants’ Ability to Enhance Hyaluronic Acid-Based Topical Moisturizers

Primary Author: Joshua Zeichner MD

Screenshot 2024-05-14 at 10.41.57 AM.png
Industry_44.png
bottom of page